Education
About Us
Working with TipRanks
Follow Us
General Cannabis (CANN)
:CANN
Top Page
General Cannabis
(OTC:CANN)
37Underperform
General Cannabis (CANN) vs. S&P 500 (SPY)
Market Cap
$3.47M
Dividend YieldN/A
Average Volume (3M)45.63K
Price to Earnings (P/E)―
Beta (1Y)0.25
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees91
SectorHealthcare
Sector Strength72
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding108,746,520
10 Day Avg. Volume49,482
30 Day Avg. Volume45,630
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.22
Price to Cash Flow (P/CF)8.10
P/FCF Ratio6.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
General Cannabis Business Overview & Revenue Model
Company DescriptionGeneral Cannabis Corp (CANN) is a diversified company operating in the cannabis industry, providing a range of products and services tailored to meet the needs of cannabis businesses. The company focuses on sectors such as real estate, consulting, and security services, offering comprehensive solutions to support the operational and developmental needs of its clients in the cannabis market.
How the Company Makes MoneyGeneral Cannabis Corp makes money through a diversified revenue model primarily centered around the cannabis industry. The company generates revenue by providing consulting services that help cannabis businesses navigate complex regulatory landscapes and optimize their operations. Another significant revenue stream is security services, which include offering specialized protection and surveillance solutions tailored to the unique needs of cannabis enterprises. Additionally, General Cannabis earns income through its real estate division, which involves leasing and selling properties designed for cannabis cultivation, processing, and retail distribution. The company also benefits from strategic partnerships and acquisitions that enhance its service offerings and expand its market reach.
General Cannabis Financial Statement Overview
Summary
General Cannabis faces significant financial challenges, as seen in declining revenues, negative profitability margins, and a precarious financial position with negative equity. The high reliance on debt and negative cash flows highlight liquidity and solvency risks. Improvement efforts should focus on cost control and revenue enhancement to stabilize the financial trajectory.Income Statement
The company has shown a declining revenue trend with a negative revenue growth rate from the previous year to TTM. Gross profit margin for TTM is approximately 38.7%, which indicates a reasonable ability to cover direct costs. However, the net profit margin remains negative due to substantial net losses, reflecting ongoing challenges in achieving profitability. EBIT and EBITDA margins are also negative, highlighting operational inefficiencies.35
Negative
Balance Sheet
The balance sheet indicates a concerning financial position with negative stockholders' equity in the TTM, suggesting insolvency risk. The debt-to-equity ratio is not meaningful due to negative equity, and ROE is negative, indicating unprofitable equity deployment. The equity ratio is also negative, underscoring a heavy reliance on debt financing, which could pose significant financial risks.25
Negative
Cash Flow
The operating cash flow is negative, and free cash flow remains negative, showing a challenging cash flow situation. The free cash flow growth rate has improved from the previous year, yet remains negative. The ratios of operating and free cash flow to net income are not favorable, indicating difficulties in converting income to cash.30
Negative
| Breakdown | |||||
| TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 11.37M | 18.14M | 13.44M | 5.93M | 7.12M | 3.67M | Gross Profit |
| 4.18M | 6.57M | 4.87M | 1.49M | 1.65M | 1.20M | EBIT |
| -1.54M | -3.97M | -3.17M | -3.01M | -6.07M | -8.86M | EBITDA |
| -3.68M | -1.64M | -5.37M | -6.12M | -6.19M | -11.33M | Net Income Common Stockholders |
| -6.95M | -7.08M | -9.48M | -10.31M | -8.53M | -14.83M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 7.96M | 969.68K | 2.58M | 2.05M | 750.22K | 122.39K | Total Assets |
| 10.74M | 23.25M | 31.69M | 22.02M | 8.52M | 3.50M | Total Debt |
| 5.27M | 17.88M | 22.54M | 10.15M | 4.76M | 2.33M | Net Debt |
| -2.68M | 16.91M | 19.96M | 8.10M | 4.01M | 2.21M | Total Liabilities |
| 6.19M | 23.10M | 25.29M | 12.42M | 7.52M | 6.25M | Stockholders Equity |
| 4.55M | 148.16K | 6.41M | 9.61M | 1.00M | -2.74M |
| Cash Flow | Free Cash Flow | ||||
| -216.65K | -1.43M | -2.11M | -2.98M | -5.32M | -5.65M | Operating Cash Flow |
| -198.41K | -1.13M | -2.05M | -2.65M | -5.00M | -5.33M | Investing Cash Flow |
| -1.48M | -304.42K | -1.95M | -978.74K | 1.11M | -753.64K | Financing Cash Flow |
| 434.33K | -184.25K | 4.53M | 4.93M | 4.42M | -1.65M |
General Cannabis Technical Analysis
Positive
0.03
Price Trends
0.03
Positive
0.03
Negative
0.04
Negative
Market Momentum
<0.01
Positive
51.63
Neutral
60.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CANN, the sentiment is Positive. The current price of 0.03 is above the 20-day moving average (MA) of 0.03, above the 50-day MA of 0.03, and below the 200-day MA of 0.04, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 51.63 is Neutral, neither overbought nor oversold. The STOCH value of 60.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CANN.
General Cannabis Risk Analysis
General Cannabis disclosed 33 risk factors in its most recent earnings report. General Cannabis reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
General Cannabis Peers Comparison
Overall Rating
UnderperformOutperform
Sector (49)
Financial Indicators
Performance Comparison
CANN
General Cannabis
0.03
-0.07
-70.00%
MJNA
Medical Marijuana
―
―
―
CVSI
CV Sciences
0.03
-0.01
-25.00%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.